DIRS.INFO The most relevant business & tech news

☆ Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy's playbook
▼ + stars: | 2024-11-20 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +2 min

The board of Acurx Pharmaceuticals approved Wednesday the purchase of up to $1 million in bitcoin to hold as a treasury reserve asset. "This new treasury strategy is a finance strategy and has no impact on our overarching drug development plans." On an X spaces event Tuesday evening, MicroStrategy Chairman and bitcoin evangelist Michael Saylor said he plans to pitch the board of Microsoft in December on his bitcoin treasury strategy. The theme has broadened to the government level this year, with Sen. Cynthia Lummis proposing a national strategic bitcoin reserve this summer. President-elect Trump similarly made mention of a potential national bitcoin stockpile in the same week.

Persons: David P, Luci, MicroStrategy, Donald Trump's, Michael Saylor, Sen, Cynthia Lummis, Trump Organizations: Acurx Pharmaceuticals, Semler, Microsoft Locations: bitcoin

☆ Three global stocks stocks to own in 2025, according to Barclays
▼ + stars: | 2024-11-20 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +3 min

The outlook for equity markets looks "decent" going into 2025, according to Barclays, as central banks cut interest rates and the global economy remains resilient. The bank named "overweight-rated stocks in which our analysts have high conviction in 2025 and see value in owning on an individual basis." Here are three of Barclays' top picks, which it gives over 35% upside potential: Shell Barclays is bullish on Shell and has a target price of £36 ($45.60) on the stock, giving it around 40% upside potential. They are currently trading around a three-times discount to their five-year average, Barclays' analysts said. Barclays has a target price of 160 euros ($169.50) on the Amsterdam-listed stock, giving it 44% potential upside.

Persons: BeSi, — CNBC's Michael Bloom Organizations: Barclays, Shell Barclays, Shell, London Stock Exchange, AstraZeneca, London, Stockholm Stock Exchanges, BE Semiconductor, BE Semiconductor Industries, Euronext Locations: U.S, —, Euronext Amsterdam, Amsterdam

☆ Bristol Myers suddenly has a big lead in schizophrenia treatment, says Jim Cramer
▼ + stars: | 2024-11-18 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

Bristol Myers suddenly has a big lead in schizophrenia treatment, says Jim Cramer'Mad Money' host Jim Cramer looks at recent stock movement in pharmaceuticals.

Persons: Bristol Myers, Jim Cramer

☆ Weight-loss drug Wegovy launched in China
▼ + stars: | 2024-11-18 | by ( ) edition.cnn.com time to read: +1 min

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity. The move intensifies the competition with Eli Lilly, which secured approval for its weight-loss drug in China in July but has yet to launch it. Both companies are ramping up production to capitalize on a weight-loss market projected by analysts to exceed $150 billion by the beginning of the next decade. Novo gained approval for Wegovy in China in June and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. Novo (NVO) launched Wegovy in the US in 2021.

Persons: Eli Lilly, Novo, Wegovy Organizations: Novo Nordisk, drugmaker, Reuters Locations: China, United States

☆ Wall Street looks for Nvidia to take the baton from election trades to keep rally alive in the week ahead
▼ + stars: | 2024-11-15 | by ( Sarah Min | ) www.cnbc.com time to read: +7 min

What exactly President-elect Donald Trump's second term means for the stock market will be the question investors continue to grapple with in the week ahead. Nvidia earnings results will also be on deck as investors deal with stubbornly high interest rates as well. The Dow Jones Industrial Average surged past 44,000 for the first time ever, and the S & P 500 and the Nasdaq Composite similarly posted new records. Sales of Blackwell and Grace Blackwell are expected to start to show up in results next year. The SPDR S & P Regional Banking ETF has surged 11% this month.

Persons: Donald Trump's, Jimmy Chang, Jensen Huang, CNBC's, Blackwell, Grace Blackwell, Harsh Kumar, Piper Sandler, Kumar, Jensen, Donald Trump, Robert F, Kennedy Jr, Novavax, Ken Mahoney, Trump, There's, Mahoney, Rockefeller's Chang, Chris Rupkey, Jerome Powell Organizations: Dow Jones, Nasdaq, Rockefeller Global Family, Treasury, Nvidia, Blackwell, Health, Human Services Department, Moderna, Asset Management, Regional Banking ETF, Federal, White, FWDBONDS, Housing, Walmart, Lowe's, Palo Alto Networks, Philadelphia Fed, . Kansas City Fed Manufacturing, Ross Stores, Intuit, Deere, PMI, PMI Manufacturing, PMI Services Locations: China, U.S, NAHB, . Kansas, Michigan

☆ Why Elon Musk's push to cut federal waste might succeed where others failed
▼ + stars: | 2024-11-15 | by ( Jack Newsham | ) www.businessinsider.com time to read: +8 min

Elon Musk and Vivek Ramaswamy are promising to tame the federal government. Substantial changes to the federal budget would most likely require action from legislators, though Trump transition officials are reportedly looking for ways to short-circuit Congress' power over spending. AdvertisementPast presidents have tried to cut the federal budget with mixed successThe federal government isn't a business. AdvertisementClinton took another stab at cutting federal spending and improving government processes with his National Performance Review, which was led and staffed by federal employees instead of the private sector. AdvertisementSocial Security and Medicare are the two single biggest areas of federal spending, and changing them could be politically unpopular.

Persons: Elon Musk, Vivek Ramaswamy, they've, Trump, Reagan, Clinton, Ronald Reagan, Bill Clinton, David Walker, J, Peter Grace, Grace, didn't, Musk, Ramaswamy, Thomas Schatz, hasn't, Lex Fridman's, Veronique de Rugy, —, de Rugy Organizations: Government, Department of Government, Trump, Congress, Government Waste, Grace, Office, Citizens, Securities and Exchange Commission, Federal Aviation Administration, SpaceX, Social, Cato Institute, Social Security, GOP

☆ Inside Microsoft's struggles with Copilot
▼ + stars: | 2024-11-15 | by ( Ashley Stewart | ) www.businessinsider.com time to read: +23 min

In September 2023, Microsoft's famously soft-spoken CEO, Satya Nadella, unveiled the company's flagship AI product, Copilot, with sweeping fanfare. Some of Microsoft's own employees and executives are privately concerned that Copilot won't be able to deliver on its ambitions. Copilot's struggles have created an opening for Microsoft's rivals, some of whom have seized on the opportunity to promote their own agendas. "Now, when Joe Blow logs into an account and kicks off Copilot, they can see everything," said one Microsoft employee familiar with customer complaints. As complaints and questions over Copilot mount, so does the pressure to justify Microsoft's unprecedented level of spending on AI.

Persons: Microsoft's, Satya Nadella, Gartner, Copilot, it'll, Copilot's, Marc Benioff, Benioff, Goldman Sachs, Marc Andreessen, Andreessen Horowitz, Ethan Miller, Jared Spataro, Spataro, —, Joe Blow, Joe, Nadella, Gary Marcus, Marcus, Wile, Coyote, Brontë, Judson Althoff, Jason Zander, Zander, We've, OpenAI, Tasos Katopodis, Steve Jobs Organizations: Microsoft, Venture, Getty, Goldman, BI, Fortune, Excel, Lumen Technologies, Honeywell, Gartner, Wall Street, Initiative, Department of Homeland Security, Employees, San Francisco, Software, Apple, Jobs Locations: Microsoft's, Copilot, New York City

☆ Jim Cramer names hot sectors that could use a pullback
▼ + stars: | 2024-11-14 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

CNBC's Jim Cramer on Thursday suggested the post-election market has been extreme, with big wins and big losses. "We have a lot of overly loved stocks in this market right now," he said. Cramer pointed out the sharp rise of enterprise software stocks, saying that it seems these companies with in-demand products for big corporations can do no wrong. Cramer also highlighted two sectors he said are "too hated," but could bounce back, including pharmaceuticals and semiconductors. For semiconductors, Cramer concluded that those companies have suffered in part because some feel that new artificial intelligence-powered PCs haven't taken off.

Persons: CNBC's Jim Cramer, Cramer, Salesforce, Donald Trump's, Trump, Robert F, Kennedy Jr Organizations: Costco, Netflix, Spotify, Merck, Pfizer, Human Services Department Locations: China

☆ This Trump trade is an underappreciated opportunity, says Janus Henderson
▼ + stars: | 2024-11-12 | by ( Michelle Fox | ) www.cnbc.com time to read: +2 min

Financial and energy stocks have jumped since last week's election, but there's another area of opportunity that investors could be missing out on, according to Janus Henderson. The market has rallied since President-elect Donald Trump' s victory, although it took a breather on Tuesday. However, financial stocks may have "gotten in a bit ahead of themselves," said Jeremiah Buckley, a portfolio manager at Janus Henderson. In addition, there is great research and development happening in health care right now, especially in health-care services, Buckley added. Among the funds Buckley oversees at Janus Henderson is the U.S. Dividend Income Fund .

Persons: Janus Henderson, Donald Trump, Jeremiah Buckley, Trump, Buckley, Eli Lilly, Amgen Organizations: Trump, P Health Care Services, UnitedHealth, Gilead Sciences

☆ I’m a neuroscientist who taught rats to drive − their joy suggests how anticipating fun can enrich human life
▼ + stars: | 2024-11-12 | by ( Analysis Kelly Lambert | The Conversation | ) edition.cnn.com time to read: +10 min

After we published our research, the story of driving rats went viral in the media. The tale of rat tailsIt wasn’t just the effects of anticipation on rat behavior that caught our attention. While it’s vital to study negative emotions such as fear and stress, positive experiences also shape the brain in significant ways. As animals – human or otherwise – navigate the unpredictability of life, anticipating positive experiences helps drive a persistence to keep searching for life’s rewards. That’s a lesson my lab rats have taught me well.

Persons: –, John McManus, Kitty Hartvigsen, neuroscientists, what’s, Jaak Panksepp, ’, jomo ’, Curt Richter, Dr, Sanjay Gupta Organizations: CNN, jomo, Get CNN, CNN Health Locations: Rat, behaviorceuticals

☆ Europe faces a 'full-blown recession' under Trump's tariffs, big bank says
▼ + stars: | 2024-11-11 | by ( Polly Thompson | Will Martin | ) www.businessinsider.com time to read: +3 min

Europe could fall into recession in 2025 under Trump's economic proposals, a major EU bank said. AdvertisementThe eurozone economy faces the possibility of a looming recession as tariffs promised by President-elect Trump look set to dampen growth, according to analysts at a Dutch bank. Trump pledged on the campaign trail to impose a fresh era of trade tariffs, building on policies he enacted during his first term as president. European Union economic growth is already struggling, and has lagged behind the US in recent years. He said Europe's economic challenges, including high energy costs, sluggish economic growth, and geopolitical instability, would only get worse in the event of a tariff battle with the US.

Persons: —, Trump, James Knightley, Nigel Green, Green Organizations: ING, Service, Trump, deVere Locations: Europe, China, Europe's, Ukraine, NATO

☆ CEOs around the world started talking about Trump's tariffs as soon as he won
▼ + stars: | 2024-11-08 | by ( Polly Thompson | ) www.businessinsider.com time to read: +8 min

It is months before Trump's inauguration, but tariffs are already on the lips of global business leaders. AdvertisementAs soon as Donald Trump won reelection, CEOs worldwide discussed his plans for a new era of global tariffs. AdvertisementOn Wednesday, Oliver Zipse, chairman of BMW, downplayed fears over tariffs during a third-quarter earnings call, citing the company's large US business. Advertisement"Politics is politics," Ikea's CEO, Jesper Brodin, told Business Insider when asked about how Trump's tariffs would affect international business. Soon after Trump's departure from the White House, the two sides ended their dispute and axed the tariffs, but renewed tariffs could lead to issues once again.

Persons: Donald Trump, Ralph Lauren, —, Trump, he'd, John Deere, Trump's, Shinju Aoyama, Aoyama, Shinji Aoyama, YOSHIKAZU, Piyush Gupta, Gupta, Europe Trump, Davidson, Oliver Zipse, Zipse, Maja Hitij, Arne Freundt, Freundt, Jesper Brodin, Guillaume Faury, Faury, OZAN KOSE, Martin Sorrell, Sorrell, Justin Picicci, Ralph Lauren's, Picicci, Timothy Boyle Organizations: BMW, Airbus, Ikea, Service, Biden, Japan's Honda Motors, Honda, Getty, DBS, Mercedes, Volkswagen, Puma, European Union, Boeing, EU, White, North, Columbia, Washington Post Locations: China, Mexico, Europe, AFP

☆ These are the most overbought stocks after Trump's win this week
▼ + stars: | 2024-11-08 | by ( Pia Singh | In | ) www.cnbc.com time to read: +4 min

Several software companies could be due for a pullback after the stock market's roaring rally this week, fueled by president-elect Donald Trump's election victory as well as robust quarterly earnings reports. Shares of video game makers Take-Two Interactive Software and Electronic Arts are two of the stocks that are technically overbought right now, according to the analysis. The most overbought stock this week was human capital management software company Dayforce, with an RSI of 92.4. But higher prices and expectations of normalizing pricing, which helped Coke guide its organic revenue growth this year to the high end of a prior forecast, could lead the stocks higher. Other oversold stocks include power generation company AES , as well as radio frequency equipment maker Qorvo and Regeneron Pharmaceuticals — the latter two of which were also oversold the previous week.

Persons: Donald Trump's, Trump, Morgan Stanley, Mills, Dr Pepper Organizations: Major, Dow Jones, Nasdaq, CNBC Pro, Companies, Electronic Arts, Software, Gilead Sciences, AES, Regeneron Pharmaceuticals Locations: Major U.S, Gilead

Trump defeated Democratic candidate Vice President Kamala Harris, and Republicans claimed a majority of the Senate in elections this week. "We know kind of where the world is headed in a Trump environment because we've seen it before," said Jeffrey Solomon, president of TD Cowen, on CNBC's "Money Movers" Wednesday. One M&A advisor, who also spoke to CNBC anonymously, noted that Trump's disdain for Big Tech companies — historically active deal-makers — might keep them on the sidelines. Apparent GOP opposition to the CHIPS Act means that semiconductor consolidation might be challenging, the advisor noted, while cautioning it is still too early to know what a Trump presidency would mean. That advisor noted that smaller banks had been getting gobbled up for "some time," but that the pace and size of those acquisitions would likely ramp up under a Trump presidency.

Persons: Donald Trum, Ronda Churchill, Donald Trump, Kamala Harris, Jeffrey Solomon, TD Cowen, Solomon, Trump, Lina Khan, Khan, Howard Gutman, Jonathan Miller, —, Jared Holz, Mizuho, Sen, Elizabeth Warren, David Zaslav, David Grogan Organizations: Republican, Nevada GOP, Afp, Getty, Trump, Democratic, Republicans, Biden administration's Department of Justice, Federal Trade Commission, CNBC, Dow Jones, MorganFranklin Consulting, Big Tech, Qualcomm, Intel, Integrated Media, Pharmaceutical, Biotech, Illumina, FTC, Maze Therapeutics, Sanofi, Senate, DOJ, Allen & Company Sun Valley Conference Locations: Florida, Nevada, Las Vegas , Nevada, Ronda, Trump, Sun Valley , Idaho

☆ The world prepares for a fresh era of tariffs under Trump 2.0
▼ + stars: | 2024-11-06 | by ( Polly Thompson | ) www.businessinsider.com time to read: +7 min

During his first term, Trump imposed tariffs on key industries in both Europe and China. AdvertisementThis time around, analysts told BI that Trump's policies could have a particular impact on Europe. Related storiesEurope is particularly vulnerable to Trump's aggressive trade policies for two main reasons, said Nigel Green, CEO of financial advisory firm deVere Group. AdvertisementDonald Trump met European Commission President Ursula von der Leyen at the World Economic Forum in Davos in 2020. Steven Kennedy, the most senior civil servant in Australia's Treasury department, said Wednesday he expected Trump's tariffs to impact the country's economy.

Persons: Donald Trump's, Trump, —, Donald Trump, Bilal Hafeez, Nigel Green, Green, Morningstar, Trump's, Michael Brown, Ursula von der Leyen, JIM WATSON, Steven Kennedy, Kennedy, Fitch, Latinvex Organizations: Service, European Union, Macro, Economic, of Chicago, Street Journal, deVere, Pharmaceuticals, Morningstar DBRS, Trump, stoke, European, Getty, European Commission, Treasury, News.com.au Locations: Europe, China, Ukraine, Davos, Australasia, Latin America, America, Mexico

☆ Stocks making the biggest moves midday: Super Micro Computer, Tesla, Coinbase, Planet Fitness and more
▼ + stars: | 2024-11-06 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +4 min

Crypto stocks — Cryptocurrency-related names soared after investors bet that a Trump presidency would lead to a more supportive regulatory environment. Cannabis stocks — Shares of cannabis companies dropped after voters rejected a Florida ballot measure to legalize the sale and use of marijuana in the state. Dollar Tree and Dollar General also respectively lost more than 6% and 5%. Steel stocks — U.S.-based steel stocks rallied on the back of Trump's victory. Shares of Nucor and Cleveland-Cliffs respectively rallied 16% and 20%, while United States Steel climbed 8%.

Persons: Donald Trump, Donald Trump's, Trump, Tesla, bitcoin, Goldman Sachs, Wells, Joe Biden's, Sunrun, Wegovy, CoreCivic, Trump's, — CNBC's Michelle Fox, Alex Harring, Hakyung Kim, Sarah Min, Samantha Subin Organizations: Republican, Trump Media & Technology, Bank, Citigroup, Bank of America, Wells Fargo, CVS Health, CVS, Trump, SolarEdge Technologies, Enphase Energy, Novo Nordisk —, Novo Nordisk, — Geo, White, Aurora Cannabis, —, CNBC, Holdings, Steel, U.S, Cliffs, United States Steel Locations: Novo Nordisk — U.S, Danish, Florida, Tilray, U.S, Canada, China, Cleveland

☆ AstraZeneca shares fall on report of potential China probe fallout
▼ + stars: | 2024-11-05 | by ( ) www.cnbc.com time to read: +2 min

The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. "As a matter of policy, we do not comment on speculative media reports including those related to ongoing investigations in China," AstraZeneca said. "If requested, we will fully cooperate with the Chinese authorities," the company added and said that its operations and delivery of medicines were ongoing in China. AstraZeneca is one of the biggest multinational drugmakers in China, which accounts for 13% of its overall revenue. In 2022, Chinese authorities had summoned AstraZeneca officials over an investigation of suspected medical insurance fraud by its employees, and had ordered that the drugmaker tighten its marketing activities.

Persons: Leon Wang, Wang, AstraZeneca Organizations: Astrazeneca, Artificial Intelligence, AstraZeneca, country's pharma Locations: Shanghai, China, Swedish

☆ 4 portfolio stocks tied to tariff-risk jump — plus, mixed signals about another
▼ + stars: | 2024-11-04 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

We're wondering if the amount of supply hitting the Treasury market is becoming more of a factor. For example, stocks with tariff risk like Club stocks Best Buy , Stanley Black & Decker , Home Depot , and Constellation Brands rallied. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Donald Trump, Stanley Black, Bill Newlands, Tom Jorden, It's, Piper Sandler, Piper, Wynn, Archer Daniels, Jim Cramer's, Jim Organizations: CNBC, ., Stocks, Treasury, Constellation Brands, Constellation, Energy, Wynn Resorts, Astera Labs, Diamondback Energy, Vertex Pharmaceuticals, DuPont, Archer Daniels Midland, Restaurant Brands, Emerson, Jim Cramer's Charitable Locations: Tuesday's, Modelo, Corona, Jorden, Cleveland, China

☆ These are the most overbought stocks as November kicks off
▼ + stars: | 2024-11-01 | by ( Pia Singh | In | ) www.cnbc.com time to read: +4 min

Investors have been accumulating shares of several big-name companies, from GE Vernova to United Airlines , during the market's recent dip. But those and other overbought stocks could be due for a pullback, according to one popular yardstick. Strong earnings from tech giants Amazon and Intel late Thursday were partly responsible for equity gains on Friday, as investors still look to megacap tech stocks for leadership. CNBC Pro screened for stocks that are considered technically overbought on the basis of their 14-day relative strength index, or RSI. Companies with a 14-day RSI above 70 are often regarded as overbought, signaling a pullback may be ahead, while a 14-day RSI below 30 often suggests a stock is oversold and could see future upside.

Persons: Nicole DeBlase, DeBlase, FactSet, Estée Lauder, Dr Pepper Organizations: GE Vernova, United Airlines, Dow, Nasdaq, Amazon, Intel, CNBC Pro, Companies, GE, FactSet, Electric, Deutsche Bank, Pharmaceuticals, eBay Locations: United, U.S, Chicago, China

☆ Meet Glean, the enterprise AI search company that's so powerful Sam Altman deemed it a threat to OpenAI
▼ + stars: | 2024-10-31 | by ( Sri Muppidi | ) www.businessinsider.com time to read: +10 min

Among them are Anthropic, Elon Musk's xAI, OpenAI cofounder Ilya Sutskever's Safe Superintelligence, and AI search startup Perplexity. The last of the five rivals, and perhaps the least well-known, is Glean, an enterprise search assistant. Founded in 2019 by Rubrik cofounder and ex-Googler Arvind Jain, Glean helps corporate workers find information across their companies' tools and data. Related Video Sam Altman moves to Microsoft after OpenAI fires him as CEOThe company enables AI search by integrating apps like Slack and Dropbox and powering search across their company's universe of data. AdvertisementBesides enterprise search, Glean also has an AI assistant that generates answers based on search results, such as summarizing the day's Slack messages or synthesizing multiple documents.

Persons: Glean, Jain, —, Sam Altman, Elon Musk's, Ilya Sutskever's, Googler Arvind Jain, Kleiner Perkins, Deedy Das, Larry Page, Das, Bipul Sinha, Rubrik, Mamoon Hamid, Vishwanath, Tony Gentilcore, Piyush Prahladka, …, Arvind, Hamid, Paul, Rajeev Dham, they're, Slack, Altman, It's Organizations: Google, Service, Elon Musk's xAI, DST Global, Sapphire Ventures, Sequoia, Microsoft, Sony Electronics, Entrepreneurship, Indian Institute of Technology, IIT, Menlo Ventures, IIT Delhi, University of Washington, Akamai Technologies, Technology, YouTube, Kleiner Locations: Jaipur, Indian, IIT Delhi, India, Glean, Seattle

☆ Cramer's Lightning Round: Vertex Pharmaceuticals is a buy
▼ + stars: | 2024-10-30 | by ( Julie Coleman | ) www.cnbc.com time to read: 1 min

Vertex Pharmaceuticals : "This company is doing the lord's work...I think it should be bought." CME Group : "It is one of the most consistent, great companies...It is a strong buy." T. Rowe Price Group : "I think it's such a great company...I want to buy the stock." Micron : "Enough with the selling of MU."

Persons: Rowe Price Organizations: Vertex Pharmaceuticals, Micron, MU

☆ AstraZeneca says its China operations president under investigation
▼ + stars: | 2024-10-30 | by ( ) www.cnbc.com time to read: +1 min

The office building of biopharmaceutical company AstraZeneca is being seen in Shanghai, China, on May 23, 2024. AstraZeneca 's China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending shares down as much as 5.3%. When asked about Wang's whereabouts, a company spokesperson only reiterated that the executive was under investigation. In a statement, the drugmaker said its Chinese operations were "under the leadership of the current general manager of AstraZeneca China," without providing further details. AstraZeneca shares were down 5.2% at 1352 GMT.

Persons: Leon Wang Organizations: AstraZeneca Locations: Shanghai, China, drugmakers, United States, AstraZeneca China

☆ Bringing manufacturing back to the US is a $10 trillion opportunity for the economy, Morgan Stanley says
▼ + stars: | 2024-10-30 | by ( Jennifer Sor | ) www.businessinsider.com time to read: +4 min

Morgan Stanley estimated that bringing manufacturing back to the US could add $10 trillion to the economy. The bank pointed to a 20-year stagnation of the industrial economy as production was sent offshore. AdvertisementThe US economy could unlock trillions in value over the next decade if more manufacturing activity comes back to the US, according to Morgan Stanley. The Biden administration, meanwhile, has poured billions into its push to increase chip production in the US and boost the manufacturing and industrial sectors. The cumulative effects could be "pretty profound" across the US economy, Snyder said, with the boost to industry and manufacturing bound to raise GDP.

Persons: Morgan Stanley, —, Chris Snyder, Snyder, Morgan Stanley's, Trump, Biden Organizations: Service, Biden, of Supply Management, Commerce Department, Economic

☆ Eli Lilly shares could be set for a big move if the Zepbound maker adds to its winning streak
▼ + stars: | 2024-10-29 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +6 min

Revenue from obesity treatment Zepbound is forecast to climb to $1.73 billion from $1.24 billion quarter over quarter. For the year, analysts expect Mounjaro sales to reach $4.58 billion, while Zepbound revenue is seen rising to $5.88 billion. The consensus view for combined sales of both drugs now stands at $30.19 billion, according to FactSet. Other key announcements A clinical trial is in progress that pits Zepbound against Novo Nordisk's Wegovy in obesity treatment. Beyond obesity, Lilly has begun treating patients with Kisunla, its Alzheimer's disease treatment.

Persons: Eli Lilly, Lilly, Seamus Fernandez, Morgan Stanley, Terence Flynn, David Risinger, Morgan Stanley's Flynn, Mounjaro, Cantor, Louise Chen, —, Fred Imbert Organizations: Investment, Food, Leerink, Novo Nordisk's, FDA, Kisunla Locations: U.S

Investors could win big with some of the companies reporting earnings this week that are trading below their fair valuations. About one-third of the S & P 500 , or 154 companies, as well as 10 companies in the Dow Jones Industrial Average , are due to report earnings this week. It is also shaping up to be a big week for companies within the travel, restaurant, energy and pharmaceuticals industries. Ahead of these results, CNBC Pro screened for the stocks reporting this week that are both trading at a discount and favored among Wall Street. The energy company will report earnings next Thursday.

Persons: James Hardiman, TD Cowen, Cowen, Andrew Kligerman, Nicholas Campanella Organizations: Dow Jones, Microsoft, Big Tech, Intel, CNBC Pro, Norwegian Cruise, Citi, Insurance, MetLife, Barclays, D, WEC Locations: Norwegian, Entergy

Search resuls for: "Pharmaceuticals"

25 mentions found